Epidemiologic contributions to understanding the etiology of uterine leiomyomata

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 5, 2000, Pages 821-827

  Schwartz, Stephen M ^a,b,e   Marshall, Lynn M ^c   Baird, Donna D ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON PUBLIC HEALTH DIVISION   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e NONE   (United States)

Author keywords

Epidemiology; Etiology; Risk factors; Uterine leiomyomata

Indexed keywords

SEX HORMONE;

ADULT; ANAMNESIS; ARTICLE; BEHAVIOR; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INHERITANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MENSTRUATION; METHODOLOGY; OBESITY; ONSET AGE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; UTERUS MYOMA;

EID: 0033669985     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s5821     Document Type: Article

References (61)

1. Hysterectomy in the United States, 1988-1990
2. The frequency of uterine leiomyomas
3. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race
4. Epidemiology of myomas
5. African Americans at higher risk than whites for uterine fibroids: Ultrasound evidence
6. Uterine leiomyomas: The somatic mutation theory
7. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States
8. Epidemiology of hysterectomy in the United States: Demographic and reproductive factors in a nationally representative sample
9. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives
10. Hysterectomy in the United States, 1965-84
11. The epidemiology of hysterectomy: Findings in a large cohort study
12. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis
13. The socioeconomic correlates of hysterectomies in the United States
14. Characteristics of women with hysterectomy
15. Epidemiologic characteristics of women with uterine fibroids: A case-control study
16. Dererminants of uterine fibroids
17. Risk factors for self-reported uterine fibroids: A case-control study
18. Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy
19. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: A multicentre case-control study
20. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata
21. Reproductive factors and risk of uterine fibroids
22. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women
23. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women
24. Effect of diet on oxidation of 17 beta-estradiol in vivo
25. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking
26. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: The inadequate luteal phase
27. Predictors of ovarian steroid secretion in reproductive-age women
28. Dietary fat, genes, and human health
29. Uterine myomas and smoking. Results from an Italian study
30. Restoration of human chorionic gonadotropin response in human myometrial smooth muscle cells by treatment with follicle-stimulating hormone (FSH): Evidence for the presence of FSH receptors in human myometrium
31. Cigarette smoking and urinary estrogens
32. Androgen and estrogen dynamics in pre- And postmenopausal women: A comparison between smokers and nonsmokers
33. The effect of smoking on serum progesterone, estradiol, and luteinizing hormone levels over a menstrual cycle in normal women
34. Sex hormones and adipose tissue distribution in premenopausal cigarette smokers
35. Endometrial cancer
36. Oral contraceptive use and risk of uterine fibroids
37. A prospective study of the side effects of oral contraceptives
38. Progesterone: A critical role in the pathogenesis of uterine myomas
39. Genetic basis of uterine leiomyoma: Involvement of high mobility group protein genes
40. In vivo modulation of Hmgic reduces obesity
41. Lower prevalence of benign diseases of the breast and benign tumours of the reproductive system among former college athletes compared to non-athletes
42. Diet and uterine myomas
43. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro
44. Human atherosclerotic plaque cells and leiomyoma cells
45. Tumors of smooth-muscle origin in HIV-infected children
46. Keloids: A review of the literature
47. The maine women's health study. II: Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain
48. Uterine myomas and factors associated with hysterectomy in premenopausal women
49. Clinical predictors in the natural history of uterine leiomyoma: Preliminary study
50. Risk of recurrence after myomectomy
51. Recurrence of fibroids after myomectomy: A transvaginal ultra-sonographic study
52. Cytogenetic abnormalities in uterine myomas are associated with myoma size
53. Many tumors and many genes-genetics of uterine leiomyomata
54. Growth factors and cytokines in uterine leiomyomas
55. Cytochrome P450c17 alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
56. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
57. Synthesis of catechol estrogens by human uterus and leiomyoma
58. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis